Chemotherapy in epithelial ovarian cancer

被引：78

作者：

Pignata, Sandro ^{[1
]}

Cannella, Lucia ^{[1
]}

Leopardo, Davide ^{[1
]}

Pisano, Carmela ^{[1
]}

Bruni, Giovanni Salvatore ^{[1
]}

Facchini, Gaetano ^{[1
]}

机构：

[1] Natl Canc Inst Naples, Dept Urol & Gynecol, Div Med Oncol, I-80131 Naples, Italy

来源：

CANCER LETTERS | 2011年 / 303卷 / 02期

关键词：

Ovarian cancer; Chemotherapy; PEGYLATED LIPOSOMAL DOXORUBICIN; PHASE-III TRIAL; PACLITAXEL-RESISTANT OVARIAN; GYNECOLOGIC-ONCOLOGY-GROUP; INTRAPERITONEAL CISPLATIN; INTERGROUP TRIAL; RANDOMIZED-TRIAL; INTRAVENOUS CHEMOTHERAPY; DOCETAXEL-CARBOPLATIN; 1ST-LINE TREATMENT;

D O I：

10.1016/j.canlet.2011.01.026

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Epithelial ovarian cancer is the most common type of ovarian cancer; usually occurs in women older than 50 years, and because 75% of cases are diagnosed at stage III or IV it is associated with a poor prognosis. Treatment of ovarian cancer is based on the integration of surgery and chemotherapy. Chemotherapy plays a major role both in the adjuvant treatment and in the care of patients with advanced disease. Several active drugs have been introduced in the treatment of ovarian cancer in the last decades and novel targets and agents are under evaluation. (C) 2011 Elsevier Ireland Ltd. All rights reserved.

引用

页码：73 / 83

页数：11

共 50 条

[41] The precision chemotherapy to improve the epithelial ovarian cancer prognosis
Pak, Seongeun
Choi, Youn Jin
[J]. CANCER RESEARCH, 2023, 83 (07)
[42] Pharmacology of cancer chemotherapy drugs for hyperthermic intraperitoneal peroperative chemotherapy in epithelial ovarian cancer
Kurt Van der Speeten
Anthony O Stuart
Paul H Sugarbaker
[J]. World Journal of Obstetrics and Gynecology, 2013, (04) : 143 - 152
[43] Neoadjuvant Chemotherapy in Advanced Epithelial Ovarian Cancer: An Institutional Experience
Manikandan Lakshmanan
Vijay Kumar
Arun Chaturvedi
Sanjeev Misra
Sameer Gupta
Naseem Akhtar
Shiv Rajan
Banupriya Mohan
Kavitha Jain
Sudeep Garg
[J]. Indian Journal of Gynecologic Oncology, 2019, 17
[44] Chemotherapy resistance in epithelial ovarian cancer: Mechanisms and emerging treatments
Marchetti, Claudia
De Felice, Francesca
Romito, Alessia
Iacobelli, Valentina
Sassu, Carolina Maria
Corrado, Giacomo
Ricci, Caterina
Scambia, Giovanni
Fagotti, Anna
[J]. SEMINARS IN CANCER BIOLOGY, 2021, 77 : 144 - 166
[45] IS INTRAPERITONEAL CHEMOTHERAPY IN THE MANAGEMENT OF RECURRENT EPITHELIAL OVARIAN CANCER FEASIBLE?
Park, S.
Nguyen, T.
Johns, A.
Adetuyi, O.
Lin, P.
Hakim, A.
Dellinger, T.
Leong, L.
Cristea, M.
Morgan, R.
Wakabayashi, M.
Han, E.
[J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2014, 24 (09) : 319 - 319
[46] Activity of chemotherapy in mucinous epithelial ovarian cancer: A retrospective study
Pisano, C
Greggi, S
Tambaro, R
Losito, S
Iodice, F
Di Maio, M
Ferrari, E
Falanga, M
Formato, R
Iaffaioli, VR
Pignata, S
[J]. ANTICANCER RESEARCH, 2005, 25 (05) : 3501 - 3505
[47] Advanced epithelial ovarian cancer in the elderly: Chemotherapy tolerance and outcome
Efstathiou, Eleni
Dimopoulos, Meletios A.
Bozas, George
Kastritis, Efstathios
Moulopoulos, Lia A.
Rodolakis, Alexandros
Vlahos, George
Gika, Dimitra
Papadimitriou, Christos
Bamias, Aristotelis
[J]. ANTICANCER RESEARCH, 2007, 27 (1B) : 611 - 617
[48] IP IMMUNOTHERAPY AND CHEMOTHERAPY IN ADVANCED EPITHELIAL OVARIAN-CANCER
HERNANDEZ, E
ROSENSHEIN, NB
TORRES, JPY
VILLAR, J
GRUMBINE, FC
ETTINGER, DS
DILLON, MB
KLEIN, JL
ORDER, SE
[J]. CANCER TREATMENT REPORTS, 1982, 66 (11): : 1981 - 1982
[49] The management of epithelial ovarian cancer: neoadjuvant chemotherapy and interval surgery
Allen, D. G.
[J]. SOUTHERN AFRICAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2010, 2 (02) : 67 - 68
[50] Neoadjuvant Chemotherapy in Advanced Epithelial Ovarian Cancer: An Institutional Experience
Lakshmanan, Manikandan
Kumar, Vijay
Chaturvedi, Arun
Misra, Sanjeev
Gupta, Sameer
Akhtar, Naseem
Rajan, Shiv
Mohan, Banupriya
Jain, Kavitha
Garg, Sudeep
[J]. INDIAN JOURNAL OF GYNECOLOGIC ONCOLOGY, 2019, 17 (04)

← 1 2 3 4 5 →